Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China flag China · Delayed Price · Currency is CNY
9.67
+0.39 (4.20%)
Feb 3, 2026, 3:00 PM CST

SHA:603707 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
15,62321,43924,16929,07552,05832,706
Market Cap Growth
-22.20%-11.29%-16.87%-44.15%59.17%10.12%
Enterprise Value
15,34521,79425,02430,39654,14334,595
Last Close Price
9.6713.1514.7417.5831.3220.07
PE Ratio
24.0725.95-26.6549.1440.57
Forward PE
15.3517.9519.4419.5638.8033.70
PS Ratio
4.155.466.157.8314.1211.22
PB Ratio
2.313.304.174.729.648.73
P/TBV Ratio
2.483.564.394.9110.139.35
P/FCF Ratio
17.4921.5620.14231.92214.34-
P/OCF Ratio
11.6014.2814.9348.8376.15-
EV/Sales Ratio
4.085.566.378.1914.6911.87
EV/EBITDA Ratio
19.4419.19-26.1840.8634.17
EV/EBIT Ratio
25.5422.63-29.7643.9637.28
EV/FCF Ratio
17.1821.9220.85242.46222.93-
Debt / Equity Ratio
0.360.320.450.480.380.87
Debt / EBITDA Ratio
3.071.83-2.561.553.22
Debt / FCF Ratio
2.722.092.1723.708.45-
Asset Turnover
0.380.410.400.410.460.46
Inventory Turnover
0.590.540.670.340.340.32
Quick Ratio
1.301.590.940.960.880.80
Current Ratio
2.463.412.353.073.062.41
Return on Equity (ROE)
9.98%13.45%-3.17%18.78%23.26%23.61%
Return on Assets (ROA)
3.81%6.33%-2.13%7.00%9.66%9.06%
Return on Invested Capital (ROIC)
7.93%12.35%-4.66%13.11%17.84%16.81%
Return on Capital Employed (ROCE)
8.30%12.90%-5.20%14.00%20.70%18.90%
Earnings Yield
4.16%3.85%-0.78%3.75%2.04%2.46%
FCF Yield
5.72%4.64%4.96%0.43%0.47%-2.63%
Dividend Yield
1.08%0.76%0.68%0.65%0.37%0.44%
Payout Ratio
31.80%25.81%-20.78%18.10%32.40%
Buyback Yield / Dilution
-1.33%-4.66%3.03%-2.98%0.43%-0.94%
Total Shareholder Return
-0.27%-3.90%3.71%-2.32%0.80%-0.50%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.